The vitamin E analogue α-TEA stimulates tumor autophagy and enhances antigen cross-presentation

Cancer Research

Volumn 72, Issue 14, 2012, Pages 3535-3545

  Li, Yuhuan ^a   Hahn, Tobias ^a   Garrison, Kendra ^a   Cui, Zhi Hua ^a   Thorburn, Andrew ^b   Thorburn, Jacqueline ^b   Hu, Hong Ming ^a   Akporiaye, Emmanuel T ^a  

^a EARLE A CHILES RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHERYLOXYACETIC ACID; CASPASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL; CANCER IMMUNOLOGY; CD8+ T LYMPHOCYTE; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CROSS PRESENTATION; ENZYME INHIBITION; FEMALE; IMMUNE SYSTEM; IMMUNOREACTIVITY; LUNG METASTASIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADENOCARCINOMA; ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; AUTOPHAGY; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL SURVIVAL; CROSS-PRIMING; DENDRITIC CELLS; FEMALE; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TOCOPHEROLS; VACCINATION;

EID: 84863924675     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3103     Document Type: Article

References (50)

1. Kline K, Lawson KA, Yu W, Sanders BG. Vitamin E and breast cancer prevention: current status and future potential. J Mammary Gland Biol Neoplasia 2003;8:91-102. (Pubitemid 38129952)
2. Hahn T, Jagadish B, Mash EA, Garrison K, Akporiaye ET. Alpha-tocopheryloxyacetic acid: a novel chemotherapeutic that stimulates the anti-tumor immune response. Breast Cancer Res 2011; 13:R4.
3. Kimmick GG, Bell RA, Bostick RM. Vitamin E and breast cancer: a review. Nutr Cancer 1997;27:109-17. (Pubitemid 27089683)
4. Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306:1549-56.
5. Lawson KA, Anderson K, Menchaca M, Atkinson J, Sun L, Knight V, et al. Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Mol Cancer Ther 2003;2:437-44.
6. Jia L, Yu W, Wang P, Sanders BG, Kline K. In vivo and in vitro studies of anticancer actions of alpha-TEA for human prostate cancer cells. Prostate 2008;68:849-60. (Pubitemid 351845216)
7. Hahn T, Szabo L, Gold M, Ramanathapuram L, Hurley LH, Akporiaye ET. Dietary administration of the proapoptotic vitamin e analogue {alpha}-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. Cancer Res 2006;66:9374-8. (Pubitemid 44623632)
8. Hahn T, Fried K, Hurley LH, Akporiaye ET. Orally active {alpha}- tocopheryloxyacetic acid suppresses tumor growth and multiplicity of spontaneous murine breast cancer. Mol Cancer Ther 2009;8: 1570-8.
9. Kline K, Yu W, Sanders BG. Vitamin E: mechanisms of action as tumor cell growth inhibitors. J Nutr 2001;131:161S-3S. (Pubitemid 32060640)
10. Neuzil J, Tomasetti M, Mellick AS, Alleva R, Salvatore BA, Birringer M, et al. Vitamin E analogues: a new class of inducers of apoptosis with selective anti-cancer effects. Curr Cancer Drug Targets 2004;4: 355-72. (Pubitemid 38797247)
11. Armstrong JS. Mitochondrial membrane permeabilization: the sine qua non for cell death. Bioessays 2006;28:253-60.
12. Jia L, Yu W, Wang P, Li J, Sanders BG, Kline K. Critical roles for JNK, c-Jun, and Fas/FasL-signaling in vitamin E analog-induced apoptosis in human prostate cancer cells. Prostate 2008;68: 427-41. (Pubitemid 351342648)
13. Wang P, Yu W, Hu Z, Jia L, Iyer VR, Sanders BG, et al. Involvement of JNK/p73/NOXA in vitamin E analog-induced apoptosis of human breast cancer cells. Mol Carcinog 2008;47:436-45. (Pubitemid 351822302)
14. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007;8:741-52. (Pubitemid 47312826)
15. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 2009;16:966-75.
16. Eisenberg-Lerner A, Kimchi A. The paradox of autophagy and its implication in cancer etiology and therapy. Apoptosis 2009;14: 376-91.
17. Eskelinen EL. New insights into the mechanisms of macro-autophagy in mammalian cells. Int Rev Cell Mol Biol 2008;266: 207-47.
18. Li Y, Wang LX, Yang G, Hao F, Urba WJ, Hu HM. Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res 2008;68:6889-95.
19. Munz C. Enhancing immunity through autophagy. Annu Rev Immunol 2009;27:423-49.
20. Kepp O, Tesniere A, Schlemmer F, Michaud M, Senovilla L, Zitvogel L, et al. Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis 2009;14:364-75.
21. Jordan KR, McMahan RH, Oh JZ, Pipeling MR, Pardoll DM, Kedl RM, et al. Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity. J Immunol 2008;180: 188-97.
22. Rasband WS. Image J. U. S. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2012.
23. He Y, Pimenov AA, Nayak JV, Plowey J, Falo LD Jr, Huang L. Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo. Hum Gene Ther 2000;11:547-54. (Pubitemid 30134298)
24. Kobie JJ, Wu RS, Kurt RA, Lou S, Adelman MK, Whitesell LJ, et al. Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines. Cancer Res 2003;63:1860-4. (Pubitemid 36460849)
25. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008;4: 151-75.
26. Tiwary R, Yu W, Sanders BG, Kline K. Alpha-TEA cooperates withMEK or mTOR inhibitors to induce apoptosis via targeting IRS/PI3K pathways. Br J Cancer 2011;104:101-9.
27. Wirawan E, Vande Walle L, Kersse K, Cornelis S, Claerhout S, Vanoverberghe I, et al. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis 2010;1:e18.
28. Cho DH, Jo YK, Hwang JJ, Lee YM, Roh SA, Kim JC. Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cells. Cancer Lett 2009;274:95-100.
29. Thorburn A. Studying autophagy's relationship to cell death. Autophagy 2008;4:391-4. (Pubitemid 351458110)
30. Li Y, Wang LX, Pang P, Twitty C, Fox BA, Aung S, et al. Cross-presentation of tumor associated antigens through tumor-derived autophagosomes. Autophagy 2009;5:576-7.
31. Munz C. Autophagy and antigen presentation. Cell Microbiol 2006;8:891-8. (Pubitemid 43670832)
32. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000;290:1717-21. (Pubitemid 32004796)
33. Gozuacik D, Kimchi A. Autophagy and cell death. Curr Top Dev Biol 2007;78:217-45.
34. Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004;304:1500-2. (Pubitemid 38720930)
35. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004;6:1221-8. (Pubitemid 39625121)
36. Pyo JO, Jang MH, Kwon YK, Lee HJ, Jun JI, Woo HN, et al. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem 2005;280:20722-9.
37. Djavaheri-Mergny M, Maiuri MC, Kroemer G. Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 2010;29:1717-9.
38. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010;29:5299-310.
39. Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, et al. Autophagy-dependent anticancer immuneresponses induced by chemotherapeutic agents in mice. Science 2011;334:1573-7.
40. Qian W, Liu J, Jin J, Ni W, Xu W. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via upregulation of Beclin-1. Leuk Res 2007;31:329-39. (Pubitemid 46073178)
41. Basciani S, Vona R, Matarrese P, Ascione B, Mariani S, Cauda R, et al. Imatinib interferes with survival of multidrug resistant Kaposi's sarcoma cells. FEBS Lett 2007;581:5897-903. (Pubitemid 50009360)
42. Yang W, Monroe J, Zhang Y, George D, Bremer E, Li H. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells. Cancer Lett 2006;243:217-27. (Pubitemid 44485853)
43. Zhu Y, Zhao L, Liu L, Gao P, Tian W, Wang X, et al. Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis. Protein Cell 2010;1:468-77.
44. Fields RC, Shimizu K, Mule JJ. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci U S A 1998;95:9482-7. (Pubitemid 28506257)
45. Nowak AK, Robinson BW, Lake RA. Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors. Cancer Res 2003;63:4490-6. (Pubitemid 36951021)
46. Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, et al. Caspase-dependent immunogenicity of doxorubicin- induced tumor cell death. J Exp Med 2005;202:1691-701. (Pubitemid 41815875)
47. Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell 2010;140:798-804.
48. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-23.
49. Sugamura K, Ishii N, Weinberg AD. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 2004;4:420-31. (Pubitemid 38745554)
50. Cheuk AT, Mufti GJ, Guinn BA. Role of 4-1BB:4-1BB ligand in cancer immunotherapy. Cancer Gene Ther 2004;11:215-26. (Pubitemid 38280524)